Indian stock markets extended their decline for a third consecutive session on Thursday, October 22, 2026, as selling pressure affected heavyweight companies, financial stocks and the broader market. Investors remained cautious amid inflation concerns and company-specific developments.
At 9:50 AM IST, the Nifty 50 was trading at 22,647.90, down 0.73%, while the BSE Sensex stood at 73,343.98, down 0.49%. Both the midcap and smallcap indices declined approximately 1.2%, indicating that weakness extended beyond large-cap stocks.
The selling was widespread, with 15 of the 16 major sectors recording losses in the reported morning snapshot. The figures reflect early trading conditions rather than confirmed midday or closing levels.
HDFC Bank and Reliance Industries Weigh on Benchmark Indices
Heavyweight stocks contributed to Thursday’s decline. HDFC Bank fell approximately 1.6%, while Reliance Industries declined around 1% during the morning session.
Also Read: Sensex Nifty Weekly Review: Indian Markets Fall Over 2% in Holiday-Shortened Week (Oct 19-23, 2026)
The weakness in these companies was significant because both carry substantial weight in India’s benchmark indices. Selling in large companies can influence the Sensex and Nifty even when some individual stocks manage to remain positive.
The decline across most major sectors also indicated that selling was not confined to a single industry.
Meanwhile, the simultaneous weakness in midcap and smallcap shares suggested that investors were reducing exposure across different market segments.
The market’s direction remained sensitive to corporate earnings and company-specific developments, with investors evaluating how rising costs and changing business conditions could affect profitability.
Mahindra Finance Falls as Funding Costs and Regulatory Risks Concern Investors
Mahindra & Mahindra Financial Services emerged among the notable stock-specific losers, falling approximately 6% in early trading.
The decline followed concerns raised by multiple brokerages about increasing funding costs and potential risks associated with insurance-distribution reforms.
For non-banking financial companies, borrowing costs are particularly important because they influence the difference between the interest earned on loans and the cost of financing those loans.
When funding costs rise, lenders may face pressure on profitability unless they can increase lending yields or improve operational efficiency.
Also Read: Top 10 Fresh Indian Market News Today: Q2 Results From CG Power, Jana SFB and More
Insurance-distribution reforms represent a separate concern because changes to commission structures or distribution arrangements could affect income from associated financial products.
The market reaction highlights the importance of evaluating future business risks alongside reported quarterly earnings. Strong historical performance does not necessarily eliminate concerns about funding conditions or regulatory changes.
FSSAI Notices Put Nestlé India, Abbott and Zydus Wellness in Focus
Regulatory scrutiny emerged as another important development affecting consumer and healthcare-related stocks.
The Food Safety and Standards Authority of India issued notices on October 21 concerning promotional claims for infant nutrition products and children’s nutritional drinks.
Also Read: Persistent Systems: Why Investors Should Watch Nagarro Integration
On Thursday morning, Nestlé India shares declined approximately 3%, while Abbott India fell 1.4% and Zydus Wellness lost 2%.
The regulator sought scientific evidence supporting certain digestive and immune-system benefit claims associated with Nestlé India’s Lactogen Pro 1 Powder and NAN Excella Pro Stage 1 products.
Zydus Wellness was asked to substantiate growth-related claims made in promotional material for Complan.
Separately, Abbott Healthcare was among the recipients of notices concerning social media content promoting infant milk substitutes.
Abbott said it had neither been involved in nor aware of the referenced promotional content before receiving the notice. The company also stated that it did not endorse the claims and had communicated its position to the regulator.
Nestlé India said the communication reiterated concerns previously raised about product labels and that it had already submitted a detailed response.
The notices represent regulatory scrutiny rather than final findings of wrongdoing. Any financial implications will depend on subsequent regulatory decisions and company responses.
What the Broader Market Weakness Means for Investors
Thursday’s market performance demonstrated how selling pressure can extend across companies with different business risks.
Also Read: Top 10 Fresh Indian Market News Today: Infosys, Shriram Finance and More
Heavyweight financial and industrial stocks contributed to benchmark weakness, while Mahindra Finance faced concerns about future funding costs and insurance-distribution reforms.
Meanwhile, selected consumer companies encountered regulatory questions concerning advertising claims and product communications.
These developments show why investors should evaluate individual businesses rather than assuming that every stock decline has the same underlying cause.
A falling share price may reflect immediate sentiment, changing earnings expectations or longer-term business risks. Distinguishing between these factors is essential when assessing company performance.
What Investors Should Watch During the Remaining Trading Session
The immediate focus is whether selling pressure in heavyweight stocks begins to ease and whether broader market participation improves.
Investors should monitor developments involving Mahindra Finance’s funding outlook, any additional company responses to FSSAI notices and the performance of major financial stocks.
The Nifty’s movement around 22,700 may provide a short-term reference point, although this level should not be treated as a confirmed technical support or resistance threshold.
Because the verified benchmark snapshot is from 9:50 AM IST, investors should consult updated exchange quotations before making trading decisions.
Conclusion
Indian equities remained under pressure on October 22, with losses affecting major benchmark constituents and smaller companies alike.
The day’s company-specific developments included weakness in Mahindra Finance amid funding and regulatory concerns, alongside declines in Nestlé India, Abbott India and Zydus Wellness following regulatory scrutiny of promotional claims.
These developments illustrate the importance of monitoring earnings expectations, financing conditions and regulatory compliance during periods of market volatility.
The remainder of the trading session will determine whether the selling pressure continues or whether selective buying helps stabilise benchmark indices.
Also Read: Indian Market Bloodbath: Sensex Sheds 1,100 Points From High
Financial Disclaimer: This article is published by Onetrader for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell securities. Financial markets involve risks, and investors should conduct independent research before making financial decisions. Onetrader is not registered with SEBI as an investment adviser or research analyst.
Keep learning with OneTrader
Explore structured lessons and practical guides to build your market knowledge.